Sign inJoin waitlistJoin the waitlist

Ann Mullally

Chief, Division of Hematology, Stanford University · Stanford Health Care

Credentials: · · · ·

History

Division of Hematology · Stanford Health Care
Present
Stanford Health Care
Present
Stanford Health Care
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
2007–2010
Internal Medicine
Johns Hopkins Hospital
2002–2005
UNIV COLL DUBLIN, NAT'L UNIV OF IRELAND, DUBLIN
1995–1999

Research

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Blood · 2009 · 586 citations
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
Science Translational Medicine · 2018 · 404 citations
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells
Cancer Cell · 2010 · First of 16 authors · 350 citations

Ben Ebert
21 papers
Ross Levine
10 papers
DG
Dwight Gilliland
7 papers
Omar Abdel-Wahab
7 papers · 4 as a fellow
GH
Gabriela Hobbs
6 papers
Jordan Breyfogle
6 papers
Richard Stone
6 papers
Daniel DeAngelo
5 papers
Marlise Luskin
5 papers
Martha Wadleigh
5 papers
Animesh Pardanani
4 papers
Ayalew Tefferi
4 papers

Grants

Functional and Molecular Dissection of Mutant Calreticulin in Myeloproliferative Neoplasms
National Heart, Lung, and Blood Institute · R01
Contact PI · $4.1M · Palo Alto Veterans Instit for Research
2016–2027
Elucidating Mechanisms of Therapy-Resistance to Interferon-Alfa in Myeloproliferative Neoplasm Stem Cells
National Heart, Lung, and Blood Institute · R01
PI · $2.8M · Weill Medical Coll of Cornell Univ
2023–2027
Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells
National Heart, Lung, and Blood Institute · K08
Contact PI · $686K · Brigham and Women's Hospital
2011–2016